Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Tuesday morning. The firm issued a buy rating on the stock.

Mannatech Stock Performance

Shares of MTEX stock opened at $8.50 on Tuesday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.51 and a current ratio of 1.07. The stock has a market capitalization of $15.98 million, a P/E ratio of -7.08 and a beta of 1.20. The company has a 50 day moving average price of $8.68 and a 200 day moving average price of $8.85. Mannatech has a fifty-two week low of $7.50 and a fifty-two week high of $16.38.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Mannatech stock. Tower Research Capital LLC TRC boosted its position in shares of Mannatech, Incorporated (NASDAQ:MTEX) by 167.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,575 shares of the company’s stock after acquiring an additional 987 shares during the period. Tower Research Capital LLC TRC owned about 0.08% of Mannatech worth $27,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.98% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.